🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of X-82 in...
Status
Terminated
Location
Multiple Locations
Start Date
2015-03-16
Trial ID
NCT02348359
Oculgen has begun a study of an investigational drug called OCUL101 as a po...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-17
Trial ID
NCT07520318
Treatments Being Tested
This study will evaluate the efficacy and safety of AKST4290 in combination...
Status
Completed
Location
Retina-Vitreous Associates Medical Group
Start Date
2020-01-28
Trial ID
NCT04331730
Treatments Being Tested
Idiopathic juxtafoveal telangiectasia type 1 is a rare unilateral disease t...
Status
Terminated
Location
CHU dijon Bourgogne
Start Date
2019-07-03
Trial ID
NCT03845049
This is a follow-on study to the VELOUR trial (NCT00561470). The aim of thi...
Status
Unknown
Location
Thomas Jefferson University Hospital
Start Date
2012-01
Trial ID
NCT01754272
The main objective of the study was to evaluate the effectiveness of aflibe...
Status
Completed
Location
Sanofi-Aventis Investigational Site Number 840119
Start Date
2007-11
Trial ID
NCT00561470
Primary objective was to demonstrate overall survival improvement with afli...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-08
Trial ID
NCT00519285
Treatments Being Tested
Primary Objective: To evaluate the improvement in progression-free surviva...
Status
Completed
Location
Investigational Site Number 156003
Start Date
2012-07
Trial ID
NCT01661270
Treatments Being Tested
The primary objective of the study was to demonstrate overall survival impr...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-09
Trial ID
NCT00532155
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-07-03
Trial ID
NCT03810313
Treatments Being Tested